Concepedia

Stephen S.Y. Lam

SS

8

Publications

290

Citations

8

H-Index

2008

Active since

Affiliations

University of Hong Kong(Current)

Chinese University of Hong Kong

Hong Kong Sanatorium and Hospital

Tuen Mun Hospital

Queen Elizabeth Hospital

Stephen S.Y. Lam is an author at University of Hong Kong specializing in tumor biology, cell biology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2008–2020

8

Publications

8

Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for<i>FLT3</i><i>-</i>ITD acute myeloid leukemia

Stephen S.Y. Lam, Eric S.K. Ho, Bai‐Liang He et al. · Science Translational Medicine · 2016 · 72 citations

Role of Mdm4 in drug sensitivity of breast cancer cells

Stephen S.Y. Lam, Kirsten Lodder, Amina F.A.S. Teunisse et al. · Oncogene · 2010 · 51 citations

, , +9

A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML

Cheuk Him Man, Stephen S.Y. Lam, Murphy Ka Hei Sun et al. · Blood · 2014 · 40 citations

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3

Chunxiao Zhang, Stephen S.Y. Lam, Garret M. K. Leung et al. · Cancer · 2019 · 35 citations · Full text

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying <i>TP53</i> mutations

Garret M. K. Leung, Chunxiao Zhang, Nelson K.L. Ng et al. · American Journal of Hematology · 2019 · 34 citations · Full text

Rows per page

1–5 of 8